Fibrinogen-to-albumin ratio (FAR) has been previously suggested for its significance in forecasting gastric cancer (GC) prognosis, however, the results remained conflicting.
The present work focused on clarifying FAR's accurate effect on forecasting GC prognosis via meta-analysis.
